Index of /wp-content/uploads/2025/07
Name
Last modified
Size
Description
Parent Directory
-
04-14-25_withdrawal.jpeg
2025-07-13 17:04
77K
07-03-25_emoji.jpeg
2025-07-03 00:44
59K
07-07-25_nightmares.jpeg
2025-07-07 19:13
69K
07-08-25_smartphones.jpeg
2025-07-08 14:14
47K
07-09-25_Caplyta.jpeg
2025-07-08 21:51
73K
07-10-25_excercise.jpeg
2025-07-10 12:03
106K
07-11-25_autism.jpeg
2025-07-10 20:31
102K
07-15-25_sports.jpeg
2025-07-14 19:57
170K
07-16-25_OTC.jpg
2025-07-15 20:21
240K
07-16-25_depression.jpeg
2025-07-15 20:41
146K
07-17-25_Leng.jpeg
2025-07-17 12:22
65K
07-17-25_NHS.jpeg
2025-07-16 18:28
133K
07-17-25_PAs.jpeg
2025-07-16 18:51
80K
07-21-25_tears.jpeg
2025-07-20 17:35
86K
07-22-25_music.jpeg
2025-07-21 20:35
105K
07-23-25_schizophrenia.jpeg
2025-07-23 15:35
66K
07-23-25_work.jpeg
2025-07-22 15:43
95K
07-25-25_bipolar.jpeg
2025-07-24 19:43
66K
07-28-25_menopause.jpeg
2025-07-27 16:31
462K
07-29-25_CTE.jpeg
2025-07-29 17:32
105K
07-30-25_brain-health.jpeg
2025-07-30 15:22
87K
07-31-25_skin.jpeg
2025-07-31 00:56
61K
08-01-25_extremism.jpeg
2025-07-31 20:35
97K
Aaronson-et-al_supplementary-material_25Apr2025-1.pdf
2025-07-14 15:01
354K
Breaking-News-Header.jpg
2025-07-16 18:39
17K
GLP-1-receptor-agonists-clozapine-induced-weight-gain-dual-GLP-1GIP-agonist-tirzepatide-25cr03952.pdf
2025-07-01 07:42
903K
Image.jpeg
2025-07-03 00:40
633K
JCP_Actigraphy-Measured-Sleep-Wake.jpg
2025-07-14 02:02
104K
JCP_Early-Response-to-Ketamine-for-Suicidal-Crisis.jpg
2025-07-21 17:02
67K
JCP_Effect-of-Nature-Videos.jpg
2025-07-28 14:16
236K
JCP_Exploring-Vascular-Endothelial-Growth.jpg
2025-07-08 21:16
232K
JCP_Global-Population-Based-Study.jpg
2025-07-08 21:16
93K
JCP_Individual-Participant-Data-Meta-Analysis.jpg
2025-07-08 21:16
142K
JCP_Intimate-Partner-Violence-in-Older-Adults.jpg
2025-07-08 21:16
137K
JCP_Intranasal-Esketamine.jpg
2025-07-28 14:16
86K
JCP_Ketamine-Esketamine-vigibase.jpg
2025-07-07 02:06
146K
JCP_Ketamine-Safety.jpg
2025-07-14 02:02
92K
JCP_Metalloproteinase-9.jpg
2025-07-14 02:02
204K
JCP_Naltrexone-Bupropion-Combination.jpg
2025-07-28 14:16
351K
JCP_Niacin-Induced-Skin-Flushing.jpg
2025-07-21 17:02
117K
JCP_Prognostic-and-Prescriptive.jpg
2025-07-14 02:02
146K
JCP_THe-Role-of-Sleep-Disruption.jpg
2025-07-28 14:16
140K
JCP_primer-meta-analysis.jpg
2025-07-07 02:18
123K
PCC_Climate-Change-and-Mental-Health.jpg
2025-07-21 20:35
493K
PCC_Functional-Neurological-Disorders-in-Active-Duty.jpg
2025-07-21 20:35
98K
PCC_GLP1-Clozapine-Weight-Gain.jpg
2025-07-04 00:55
112K
PCC_Hidden-Perils-of-Kratom.jpg
2025-07-04 00:55
244K
PCC_Hyperprolactinemia.jpg
2025-07-28 14:16
99K
PCC_Late-Onset-BPD-Preceding-Thyroid-Cancer.jpg
2025-07-14 02:02
92K
PCC_Mental-Health-Effects-Tirzepatide.jpg
2025-07-04 00:55
108K
PCC_Oral-Thyroxine.jpg
2025-07-28 14:16
103K
PCC_Preclinical-Medical-Study-Program.jpg
2025-07-28 14:16
164K
PCC_Priapism.jpg
2025-07-28 14:16
117K
PCC_Reversible-Cerebral-Vasoconstriction-Syndrome.jpg
2025-07-21 20:35
109K
PCC_Serious-Suicide-Attempts.jpg
2025-07-04 00:55
173K
PCC_Severe-Thrombocytopenia.jpg
2025-07-14 02:02
128K
PCC_Solitary-Rectal-Ulcer-Syndrome.jpg
2025-07-14 02:02
124K
Prognostic-Prescriptive-Predictors-Treatment-Response-Adjunctive-VNS-Therapy-Major-Depressive-Disorder-RECOVER-Trial-Report-25m15850-f1.png
2025-07-11 17:47
133K
Prognostic-Prescriptive-Predictors-Treatment-Response-Adjunctive-VNS-Therapy-Major-Depressive-Disorder-RECOVER-Trial-Report-25m15850-f2.png
2025-07-11 17:47
135K
Prognostic-Prescriptive-Predictors-Treatment-Response-Adjunctive-VNS-Therapy-Major-Depressive-Disorder-RECOVER-Trial-Report-25m15850-f3.png
2025-07-11 17:47
57K
Prognostic-Prescriptive-Predictors-Treatment-Response-Adjunctive-VNS-Therapy-Major-Depressive-Disorder-RECOVER-Trial-Report-25m15850-t1.png
2025-07-11 17:47
120K
Prognostic-Prescriptive-Predictors-Treatment-Response-Adjunctive-VNS-Therapy-Major-Depressive-Disorder-RECOVER-Trial-Report-25m15850.pdf
2025-07-14 15:04
2.6M
VEGF-Other-Biomarkers-Cognition-First-Episode-Psychosis-24m15486-SM.pdf
2025-07-09 10:15
302K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-f1.png
2025-07-09 00:28
65K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-f2.png
2025-07-09 00:28
90K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-f3.png
2025-07-09 00:28
108K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-t1.png
2025-07-09 00:28
99K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-t2.png
2025-07-09 00:28
116K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-t3.png
2025-07-09 00:28
92K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-t4.png
2025-07-09 00:28
45K
VEGF-other-biomarkers-cognition-first-episode-psychosis-24m15486-t5.png
2025-07-09 00:28
68K
actigraphy-measured-sleep-wake-characteristics-suicidal-ideation-older-adults-depression-high-suicide-risk-24m15522-SM.pdf
2025-07-11 16:50
197K
actigraphy-measured-sleep-wake-characteristics-suicidal-ideation-older-adults-depression-high-suicide-risk-24m15522-f1.png
2025-07-11 16:27
173K
actigraphy-measured-sleep-wake-characteristics-suicidal-ideation-older-adults-depression-high-suicide-risk-24m15522-t1.png
2025-07-11 16:27
51K
actigraphy-measured-sleep-wake-characteristics-suicidal-ideation-older-adults-depression-high-suicide-risk-24m15522-t2.png
2025-07-11 16:27
46K
actigraphy-measured-sleep-wake-characteristics-suicidal-ideation-older-adults-depression-high-suicide-risk-24m15522-t3.png
2025-07-11 16:27
48K
actigraphy-measured-sleep-wake-characteristics-suicidal-ideation-older-adults-depression-high-suicide-risk-24m15522-t4.png
2025-07-11 16:27
44K
actigraphy-measured-sleep-wake-characteristics-suicidal-ideation-older-adults-depression-high-suicide-risk-24m15522.pdf
2025-07-10 22:44
4.7M
artificial-intelligence-depression-medication-enhancement-AID-ME-cluster-randomized-trial-clinical-decision-support-system-personalized-depression-treatment-selection-management-24m15634-f1.png
2025-07-30 06:48
128K
artificial-intelligence-depression-medication-enhancement-AID-ME-cluster-randomized-trial-clinical-decision-support-system-personalized-depression-treatment-selection-management-24m15634-f2.png
2025-07-30 06:48
38K
artificial-intelligence-depression-medication-enhancement-AID-ME-cluster-randomized-trial-clinical-decision-support-system-personalized-depression-treatment-selection-management-24m15634-t1.png
2025-07-30 06:48
139K
artificial-intelligence-depression-medication-enhancement-AID-ME-cluster-randomized-trial-clinical-decision-support-system-personalized-depression-treatment-selection-management-24m15634-t2.png
2025-07-30 06:48
26K
artificial-intelligence-depression-medication-enhancement-AID-ME-cluster-randomized-trial-clinical-decision-support-system-personalized-depression-treatment-selection-management-24m15634-t3.png
2025-07-30 06:48
46K
artificial-intelligence-depression-medication-enhancement-AID-ME-cluster-randomized-trial-clinical-decision-support-system-personalized-depression-treatment-selection-management-24m15634.pdf
2025-07-30 09:35
2.4M
case-series-intimate-partner-violence-older-adults-older-persons-mental-health-service-24m15495-t1.png
2025-07-08 10:40
91K
case-series-intimate-partner-violence-older-adults-older-persons-mental-health-service-24m15495-t2.png
2025-07-08 10:40
86K
case-series-intimate-partner-violence-older-adults-older-persons-mental-health-service-24m15495-t3.png
2025-07-08 10:40
95K
case-series-intimate-partner-violence-older-adults-older-persons-mental-health-service-24m15495.pdf
2025-07-09 15:09
2.2M
climate-change-mental-health-Indian-studies-24r03903-f1.png
2025-07-21 08:14
39K
climate-change-mental-health-Indian-studies-24r03903-t1.png
2025-07-21 08:14
195K
climate-change-mental-health-Indian-studies-24r03903.pdf
2025-07-21 08:12
3.1M
early-change-depressive-symptom-severity-naltrexone-bupropion-combination-association-reduction-methamphetamine-use-ADAPT-2-Trial-25m15825-f1.png
2025-07-28 12:06
84K
early-change-depressive-symptom-severity-naltrexone-bupropion-combination-association-reduction-methamphetamine-use-ADAPT-2-Trial-25m15825-f2.png
2025-07-28 12:06
51K
early-change-depressive-symptom-severity-naltrexone-bupropion-combination-association-reduction-methamphetamine-use-ADAPT-2-Trial-25m15825-f3.png
2025-07-28 12:06
101K
early-change-depressive-symptom-severity-naltrexone-bupropion-combination-association-reduction-methamphetamine-use-ADAPT-2-Trial-25m15825-t1.png
2025-07-28 12:06
61K
early-change-depressive-symptom-severity-naltrexone-bupropion-combination-association-reduction-methamphetamine-use-ADAPT-2-Trial-25m15825-t2.png
2025-07-28 12:06
76K
early-change-depressive-symptom-severity-naltrexone-bupropion-combination-association-reduction-methamphetamine-use-ADAPT-2-Trial-25m15825.pdf
2025-07-26 17:08
3.5M
early-response-ketamine-suicidal-crisis-reduces-suicidal-events-3-months-25m15829-f1.png
2025-07-21 09:36
37K
early-response-ketamine-suicidal-crisis-reduces-suicidal-events-3-months-25m15829-t1.png
2025-07-21 09:36
78K
early-response-ketamine-suicidal-crisis-reduces-suicidal-events-3-months-25m15829-t2.png
2025-07-21 09:36
92K
early-response-ketamine-suicidal-crisis-reduces-suicidal-events-3-months-25m15829.pdf
2025-07-21 09:35
1.6M
effect-nature-videos-burden-caregivers-patients-dementia-25m15817-f1.png
2025-07-28 10:13
80K
effect-nature-videos-burden-caregivers-patients-dementia-25m15817-f2.png
2025-07-28 10:13
71K
effect-nature-videos-burden-caregivers-patients-dementia-25m15817-f3.png
2025-07-28 10:13
69K
effect-nature-videos-burden-caregivers-patients-dementia-25m15817-t1.png
2025-07-28 10:13
274K
effect-nature-videos-burden-caregivers-patients-dementia-25m15817-t2.png
2025-07-28 10:13
112K
effect-nature-videos-burden-caregivers-patients-dementia-25m15817.pdf
2025-07-26 05:35
3.4M
efficiency-extent-niacin-induced-skin-flushing-patterns-early-stages-psychosis-24m15559-eqn1.png
2025-07-17 08:36
8.7K
efficiency-extent-niacin-induced-skin-flushing-patterns-early-stages-psychosis-24m15559-f1.png
2025-07-16 08:13
162K
efficiency-extent-niacin-induced-skin-flushing-patterns-early-stages-psychosis-24m15559-f2.png
2025-07-16 08:13
147K
efficiency-extent-niacin-induced-skin-flushing-patterns-early-stages-psychosis-24m15559-f3.png
2025-07-16 08:13
309K
efficiency-extent-niacin-induced-skin-flushing-patterns-early-stages-psychosis-24m15559-t1.png
2025-07-16 08:13
92K
efficiency-extent-niacin-induced-skin-flushing-patterns-early-stages-psychosis-24m15559-t2.png
2025-07-16 08:13
85K
efficiency-extent-niacin-induced-skin-flushing-patterns-early-stages-psychosis-24m15559.pdf
2025-07-21 16:25
3.1M
functional-neurologic-disorders-active-duty-military-personnel-veterans-25f03928-t1.png
2025-07-21 09:20
80K
functional-neurologic-disorders-active-duty-military-personnel-veterans-25f03928.pdf
2025-07-21 16:09
3.5M
global-population-based-study-association-ketamine-esketamine-suicidality-who-vigibase-24m15534-f1.png
2025-07-04 11:24
46K
global-population-based-study-association-ketamine-esketamine-suicidality-who-vigibase-24m15534-f2.png
2025-07-04 11:24
47K
global-population-based-study-association-ketamine-esketamine-suicidality-who-vigibase-24m15534-t1.png
2025-07-04 11:24
90K
global-population-based-study-association-ketamine-esketamine-suicidality-who-vigibase-24m15534-t2.png
2025-07-04 11:24
97K
global-population-based-study-association-ketamine-esketamine-suicidality-who-vigibase-24m15534.pdf
2025-07-04 01:59
1.4M
hidden-perils-kratom-drug-induced-psychosis-second-generation-antipsychotics-25cr03935.pdf
2025-07-01 08:37
849K
high-dose-oral-thyroxine-optimizing-thyroid-function-ECT-schizophrenia-Hashimoto-thyroiditis-25cr03914-1.pdf
2025-07-25 15:35
2.6M
high-dose-oral-thyroxine-optimizing-thyroid-function-ECT-schizophrenia-Hashimoto-thyroiditis-25cr03914.pdf
2025-07-25 15:33
2.6M
how-do-we-get-ketamine-safety-right-3-questions-clinical-service-25com15946.pdf
2025-07-15 08:30
1.1M
hyperprolactinemia-delusion-pregnancy-association-fluphenazine-monotherapy-schizoaffective-disorder-25cr03954.pdf
2025-07-26 08:00
2.7M
klotho-matrix-metalloproteinase-9-association-inhibitory-dyscontrol-adolescents-first-episode-major-affective-disorders-24m15696-f1.png
2025-07-15 02:52
64K
klotho-matrix-metalloproteinase-9-association-inhibitory-dyscontrol-adolescents-first-episode-major-affective-disorders-24m15696-f2.png
2025-07-15 02:52
52K
klotho-matrix-metalloproteinase-9-association-inhibitory-dyscontrol-adolescents-first-episode-major-affective-disorders-24m15696-t1.png
2025-07-15 02:52
93K
klotho-matrix-metalloproteinase-9-association-inhibitory-dyscontrol-adolescents-first-episode-major-affective-disorders-24m15696-t2.png
2025-07-15 02:52
43K
klotho-matrix-metalloproteinase-9-association-inhibitory-dyscontrol-adolescents-first-episode-major-affective-disorders-24m15696.pdf
2025-07-15 08:18
1.7M
late-onset-bipolar-disorder-preceding-diagnosis-papillary-thyroid-carcinoma-25cr03936.pdf
2025-07-11 11:08
2.6M
long-term-outcomes-patients-treatment-refractory-depression-receiving-intravenous-ketamine-intranasal-esketamine-25m15831-f1.png
2025-07-29 05:36
25K
long-term-outcomes-patients-treatment-refractory-depression-receiving-intravenous-ketamine-intranasal-esketamine-25m15831-f2.png
2025-07-29 05:36
70K
long-term-outcomes-patients-treatment-refractory-depression-receiving-intravenous-ketamine-intranasal-esketamine-25m15831-f3.png
2025-07-29 05:36
75K
long-term-outcomes-patients-treatment-refractory-depression-receiving-intravenous-ketamine-intranasal-esketamine-25m15831-t1.png
2025-07-29 05:36
208K
long-term-outcomes-patients-treatment-refractory-depression-receiving-intravenous-ketamine-intranasal-esketamine-25m15831.pdf
2025-07-29 05:34
3.3M
mental-health-effects-tirzepatide-report-2-patients-25cr03931-f1.png
2025-07-08 10:24
132K
mental-health-effects-tirzepatide-report-2-patients-25cr03931.pdf
2025-07-04 05:57
2.7M
preclinical-medical-student-program-reactions-interviewing-psychiatric-inpatients-25m03923-t1.png
2025-07-26 11:40
53K
preclinical-medical-student-program-reactions-interviewing-psychiatric-inpatients-25m03923.pdf
2025-07-24 08:10
3.1M
primer-individual-participant-data-meta-analysis-strengths-limitations-25f16001-t1.png
2025-07-04 08:37
127K
primer-individual-participant-data-meta-analysis-strengths-limitations-25f16001-t2.png
2025-07-04 08:37
56K
primer-individual-participant-data-meta-analysis-strengths-limitations-25f16001-t3.png
2025-07-04 08:37
157K
primer-individual-participant-data-meta-analysis-strengths-limitations-25f16001-t4.png
2025-07-04 08:37
48K
primer-individual-participant-data-meta-analysis-strengths-limitations-25f16001.pdf
2025-07-04 07:54
1.3M
psychotropic-medication-induced-priapism-diagnosis-treatment-25f03942-f1.png
2025-07-30 07:11
75K
psychotropic-medication-induced-priapism-diagnosis-treatment-25f03942-f2.png
2025-07-30 07:11
82K
psychotropic-medication-induced-priapism-diagnosis-treatment-25f03942-f3.png
2025-07-30 07:11
87K
psychotropic-medication-induced-priapism-diagnosis-treatment-25f03942-t1.png
2025-07-30 07:11
45K
psychotropic-medication-induced-priapism-diagnosis-treatment-25f03942.pdf
2025-07-29 21:31
3.6M
psychotropic-medication-induced-priapism-diagnosis-treatment-SM-25f0942.pdf
2025-07-30 07:27
221K
reversible-cerebral-vasoconstriction-syndrome-marijuana-use-raising-awareness-25lr03959.pdf
2025-07-21 15:56
830K
safety-of-electroconvulsive-therapy-in-severe-thrombocytopenia-25cr03922-t1.png
2025-07-14 10:11
27K
safety-of-electroconvulsive-therapy-in-severe-thrombocytopenia-25cr03922.pdf
2025-07-14 10:30
2.7M
serious-suicide-attempts-assessment-management-25f03913-f1.png
2025-07-08 06:41
130K
serious-suicide-attempts-assessment-management-25f03913-t1.png
2025-07-08 06:41
120K
serious-suicide-attempts-assessment-management-25f03913-t2.png
2025-07-08 06:41
104K
serious-suicide-attempts-assessment-management-25f03913-t3.png
2025-07-08 06:41
165K
serious-suicide-attempts-assessment-management-25f03913-t4.png
2025-07-08 06:41
152K
serious-suicide-attempts-assessment-management-25f03913.pdf
2025-07-08 11:21
2.0M
solitary-rectal-ulcer-syndrome-patient-taking-fluoxetine-25cr03915-f1.png
2025-07-14 11:19
302K
solitary-rectal-ulcer-syndrome-patient-taking-fluoxetine-25cr03915-f2.png
2025-07-14 11:19
297K
solitary-rectal-ulcer-syndrome-patient-taking-fluoxetine-25cr03915.pdf
2025-07-14 11:15
3.6M
suicide-risk-patients-bipolar-disorder-role-sleep-disruption-vs-benzodiazepine-use-25lr15890.pdf
2025-07-25 14:56
2.6M
unilateral-abdominal-seizures-manifestation-neurocysticercosis-25cr03926.pdf
2025-07-31 09:00
3.0M
Apache/2.4.65 (Ubuntu) Server at www.psychiatrist.com Port 443